Asthma in pregnancy: a review of recent literature

被引:0
作者
Colas, Kelly [1 ,3 ]
Namazy, Jennifer [2 ]
机构
[1] Univ Washington, Dept Allergy & Immunol, Seattle, WA USA
[2] Dept Pediat & Adult Allergy & Immunol, Scripps Clin, San Diego, CA USA
[3] Univ Washington, Seattle Campus, Seattle, WA 98195 USA
关键词
asthma; biologics; medication safety; pregnancy; CONGENITAL-MALFORMATIONS; MATERNAL ASTHMA; INHALED CORTICOSTEROIDS; MEDICATION USE; 1ST TRIMESTER; PERINATAL OUTCOMES; LUNG-FUNCTION; RISK-FACTORS; WOMEN; MANAGEMENT;
D O I
10.1097/MCP.0000000000001072
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of reviewAsthma remains the most common respiratory disease in pregnancy. Identifying risk factors for asthma exacerbations during pregnancy is critical, as uncontrolled asthma can have detrimental effects for both mother and baby. In this review, we discuss recent literature exploring risk factors, fetal and maternal effects, and treatment options for asthma during pregnancy.Recent findingsRecent literature suggests that optimizing asthma during pregnancy improves outcomes for both mother and baby, as well as later in childhood. Current research affirms that the benefit of asthma medication use outweighs any potential risks related to the medications themselves. Limited information is available regarding the use of newer therapies such as biologics during pregnancy.SummaryIdentifying risk factors for asthma exacerbations during pregnancy is critical to prevent adverse outcomes for both mother and baby. Recent evidence continues to affirm the safety of asthma medication use; more studies are needed regarding the use of new therapies during pregnancy.
引用
收藏
页码:313 / 324
页数:12
相关论文
共 105 条
[1]  
Administration UFaD, 2021, Tezepelumab full prescribing information/ FDA access data
[2]  
Administration. UFaD, 2017, Benralizumab full prescribing information/FDA access data
[3]  
Administration UFaD, 2019, Dupilumab full prescribing information/FDA access data
[4]   Clustering of asthma and related comorbidities and their association with maternal health during pregnancy: evidence from an Australian birth cohort [J].
Ahmad, Kabir ;
Kabir, Enamul ;
Ormsby, Gail M. ;
Khanam, Rasheda .
BMC PUBLIC HEALTH, 2021, 21 (01)
[5]   The use of dupilumab in severe atopic dermatitis during pregnancy: a case report [J].
Akhtar, Nabeel H. ;
Khosravi-Hafshejani, Touraj ;
Akhtar, Daud ;
Dhadwal, Gurbir ;
Kanani, Amin .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022, 18 (01)
[6]   Excessive gestational weight gain in first trimester is a risk factor for exacerbation of asthma during pregnancy: A prospective study of 1283 pregnancies [J].
Ali, Zarqa ;
Nilas, Lisbeth ;
Ulrik, Charlotte Suppli .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) :761-767
[7]  
American Academy of Allergy Asthma and Immunology (AAAAI), 2023, Asthma and pregnancy toolkit breath 4 baby
[8]  
[Anonymous], 2017, Global Strategy for Asthma management and Prevention
[9]  
Asthma GIf, 2023, Global strategy for asthma management and prevention
[10]  
Australia NAC, Asthma management handbook version 2.1